Hextar Healthcare BhdXKLS:7803 ROA % is -2.46% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 1,619 Chemicals companies, Hextar Healthcare Bhd ranks worse than 90.55% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Hextar Healthcare Bhd's annualizedNet Income for the quarter that ended in Mar. 2026 was RM-11.7 Mil.
Hextar Healthcare Bhd's average Total Assets over the quarter that ended in Mar. 2026 was RM475.8 Mil. Therefore, Hextar Healthcare Bhd's annualized ROA % for the quarter that ended in Mar. 2026 was -2.46%.
The historical rank and industry rank for Hextar Healthcare Bhd's ROA % or its related term are showing as below:
XKLS:7803'
s ROA % Range Over the Past 10 Years
Min: -14.72 Med: 0.4 Max: 35.4
Current: -8.76
During the past 13 years, Hextar Healthcare Bhd's highest ROA % was 35.40%. The lowest was -14.72%. And the median was 0.40%.
XKLS:7803's ROA % is ranked worse than 90.55% of 1619
companies
in the Chemicals industry
Industry Median: 2.9
vs XKLS:7803: -8.76
Hextar Healthcare Bhd (XKLS:7803) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Hextar Healthcare Bhd's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hextar Healthcare Bhd ROA % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Hextar Healthcare Bhd's ROA % distribution charts can be found below:
* The bar in red indicates where Hextar Healthcare Bhd's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Hextar Healthcare Bhd (XKLS:7803) has a ROA % of -2.46% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Hextar Healthcare Bhd and its competitors. According to the industry distribution chart, Hextar Healthcare Bhd ranks #1466 out of 1619 companies in the Chemicals industry, placing it in the top 90.5%.
Is Hextar Healthcare Bhd's ROA % too high?
Hextar Healthcare Bhd's current ROA % is -2.46%. Based on the distribution chart, Hextar Healthcare Bhd ranks #1466 out of 1619 companies in the Chemicals industry, which is in the bottom quartile relative to peers.
How does Hextar Healthcare Bhd's ROA % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Hextar Healthcare Bhd ranks #1466 out of 1619 companies for ROA %. This places Hextar Healthcare Bhd in the lower half of its industry. The industry median ROA % is 2.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Chemicals company?
The median ROA % among Chemicals companies is 2.90, based on 1,619 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Hextar Healthcare Bhd and its competitors. For the Chemicals industry, the median ROA % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hextar Healthcare Bhd's current ROA % is -2.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hextar Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Hextar Healthcare Bhd (XKLS:7803) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.16, compared to a current price of RM0.06 — trading 62.5% below its estimated fair value. The current ROA % is -2.46%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Hextar Healthcare Bhd (XKLS:7803), the current ROA % is -2.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hextar Healthcare Bhd is principally involved in investment holding. Through its subsidiaries, it manufactures and sells rubber gloves. The company offers a wide range of industrial and safety gloves, household rubber gloves, and disposable vinyl and nitrile gloves. The company operates in three segments: Gloves operation, Medical devices operation, and Investment holding. The company generates the majority of its revenue from the Gloves operation segment. It has operations in Europe, Asia, North and South America, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7803 has been successfully added to your 